Filing Details
- Accession Number:
- 0000899243-18-009681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-06 18:01:14
- Reporting Period:
- 2018-04-03
- Accepted Time:
- 2018-04-06 18:01:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588538 | Robert Ernest Paolantonio De | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | Cfo, Secretary And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-03 | 1,267 | $0.00 | 97,731 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2018-04-03 | 34,391 | $0.00 | 132,122 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-04-03 | 30,000 | $0.00 | 162,122 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-04-03 | 31,667 | $0.00 | 193,789 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-04-03 | 27,075 | $0.00 | 220,864 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-05 | 30,900 | $2.12 | 189,864 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-06 | 33,255 | $2.06 | 156,709 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-04-03 | 1,267 | $0.00 | 1,267 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-04-03 | 34,391 | $0.00 | 34,391 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-04-03 | 30,000 | $0.00 | 30,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-04-03 | 31,667 | $0.00 | 31,667 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2018-04-03 | 27,075 | $0.00 | 27,075 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-04-03 | No | 4 | A | Direct | |
| 0 | 2018-04-03 | No | 4 | M | Direct | |
| 30,000 | 2019-03-01 | No | 4 | M | Direct | |
| 63,333 | 2020-02-06 | No | 4 | M | Direct | |
| 0 | 2020-02-06 | No | 4 | A | Direct |
Footnotes
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's Long-Term Incentive Plan.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended (the "EIP"). Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs that were granted to the Reporting Person on February 29, 2016, pursuant to a grant under the EIP. The remainder of the RSUs under this grant will vest on March 1, 2019.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 6, 2017 under the EIP. The remainder of the RSUs under this grant will vest in equal portions after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the performance-based RSUs ("Performance RSUs") granted to the Reporting Person on February 6, 2017 under the EIP subject to certain performance measures. The remainder of the Performance RSUs under this grant will vest, in equal amounts, but subject to certain performance measures, after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020.
- The shares of common stock were sold by the Reporting Person upon expiration of a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's additional tax liability upon the vesting of the Reporting Person's RSUs.
- On April 5, 2018, the Reporting Person sold an aggregate of 30,900 shares of the Issuer's Common Stock at a weighted average price of $2.12 per share. The highest sale price for the Common Stock was $2.15 per share and the lowest sale price was $2.08 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On April 6, 2018, the Reporting Person sold an aggregate of 33,255 shares of the Issuer's Common Stock at a weighted average price of $2.06 per share. The highest sale price for the Common Stock was $2.15 per share and the lowest sale price was $2.00 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
